Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL7084475

COC(=O)c1ccc(N)c(C(=O)c2ccc(C(C)(C)C)cc2)c1.N

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.51
HPGD P15428 5/20 0.51
MAPT P10636 5/20 0.51
GAA P10253 4/20 0.51
KDM4E B2RXH2 4/20 0.51
HSD17B10 Q99714 3/20 0.51
GLA P06280 1/20 0.51
CASP1 P29466 1/20 0.51
CASP7 P55210 1/20 0.51
ATM Q13315 1/20 0.51
LMNA P02545 2/20 0.51
KIF11 P52732 1/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46
NPSR1 Q6W5P4 1/20 0.45
PKM P14618 1/20 0.45
CFTR P13569 2/20 0.44
SRD5A2 P31213 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14579889 0.81 SRD5A2 (0.50) MAPTGAAKDM4ECA1CA2
SCHEMBL2912873 0.78 KDM4E (0.73) ALDH1A1HPGDMAPTGAAKDM4E
SCHEMBL14579888 0.78 MAPT (0.70) ALDH1A1MAPTGAAKDM4EGLA
SCHEMBL9574892 0.78 MAPT (0.56) ALDH1A1HPGDMAPTGAAKDM4E
SCHEMBL5226208 0.78 HDAC1 (0.70) ALDH1A1HPGDMAPTGAAKDM4E
SCHEMBL6172186 0.78 ALDH1A1 (0.48) ALDH1A1HPGDMAPTGAAKDM4E
SCHEMBL2054575 0.77 ALDH1A1 (0.58) ALDH1A1HPGDMAPTGAAKDM4E
SCHEMBL30437832 0.77 KDM4E (0.57) ALDH1A1HPGDMAPTGAAKDM4E
SCHEMBL20690360 0.77 KDM4E (0.57) ALDH1A1HPGDMAPTGAAKDM4E
SCHEMBL11287507 0.77 GAA (0.47) ALDH1A1HPGDMAPTGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030195223-A1 An anticoagulant, blood inhibitor of factor Xa, a N1-amidinebenzoyl- N2-benzoyl-1,2-benzenediamine derivatives; chemical intermediates BEIGHT DOUGLAS WADE (US) 2003-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030195223-A1 An anticoagulant, blood inhibitor of factor Xa, a N1-amidinebenzoyl- N2-benzoyl-1,2-benzenediamine derivatives; chemical intermediates F12, F11, F2 ALDH1A1 1095/4885HPGD 690/4885MAPT 4629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.